How dependent is India on mRNA Lipid Nanoparticles imports?

India imports $0.09 bn, mostly from Canada. Its Critical Manufacturing Dependency Index is 66.59/100 (High), with a localisation potential of 58.

mRNA Lipid Nanoparticles

High dependencyBuild-nowPharmaceuticals & APIsReasoned estimateHS 2923.19

$0.09 bnAnnual import

21%Indian capability

5,238Supplier concentration (HHI)

₹2,431 crTo localise

Why India imports it. Reasoned estimate: India has limited domestic capacity for mrna lipid nanoparticles; sector trade patterns indicate continued import reliance.

Why it matters. Strategic dependency within pharma value chain; affects downstream manufacturing competitiveness.

Can India localise it? Partial

Where it comes from. Canada (63%), China (25%), USA (12%).

Scorecard

The ten indices

CMDI 66.59Dependency

LPI 58Localisation potential

IAI 66.25Investment attractiveness

SRI 65.92Supply risk

SCI 51.5Supply-chain complexity

TRI 43.75Technology readiness

IMI 66.5Industrial multiplier

NSRI 57.25National-security relevance

EPI 65.25Export potential

ICGI 60.62Capability gap

Intelligence

Related signals

Sources

Primary references

pharmaceuticals.gov.in ↗

Confidence: Reasoned estimate. Reasoned estimate derived from sector trade patterns and HS code classification; specific company/number values are modelled. Part of Techadyant Labs' Critical Manufacturing Dependencies (Edition I).